Tuberculosis with human immunodeficiency virus infection

Indian Journal of Pediatrics

Volumn 67, Issue 2 SUPPL., 2000, Pages

  Cherian, Thomas ^a   Verghese, Valsan P ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

HIV infected; Latent infection

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

BCG VACCINATION; CHILD; CLINICAL FEATURE; CLINICAL PROTOCOL; COMORBIDITY; DEVELOPING COUNTRY; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION PREVENTION; LABORATORY DIAGNOSIS; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; PREVALENCE; RADIODIAGNOSIS; REVIEW; SEROPREVALENCE; TREATMENT OUTCOME; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BCG VACCINE; CHILD; HIV INFECTIONS; HUMANS; ISONIAZID; RISK FACTORS; TUBERCULOSIS;

EID: 0033661611     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Centers for Disease Control and Prevention. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 38: 236-8, 243-50.
2. Centers for Disease Control and Prevention. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43 (No. RR-12): 1-19.
3. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-6.
4. Misra SN, Sengupta D, Satpathy SK. AIDS in India: recent trends in opportunistic infections. Southeast Asian J Trop Med Public Health 1998; 29: 37-6.
5. Kumarnswamy N, Solomon S, Jayaker Paul SA, Venilla R, Amalraj RE. Spectrum of opportunistic infections among AIDS patients in Tamilnadu. Int J STD AIDS 1995; 6: 447-9.
6. Kaur A, Babu PG, Jacob M et al. Clinical and laboratory profile of AIDS in India. J Acquir Immune Def. Syndr 1992; 5: 883-9.
7. Paranjape RS, Tripathy SP, Menon PA et al. Increasing trend of HIV seroprevalence among pulmonary tuberculosis patients in Pune. Indian J Med Res 1997; 106: 207-11.
8. Merchant RH, Shroff RC. HIV seroprevalence in disseminated tuberculosis and chronic diarrhea, Indian Pediatr 1998; 35: 883-7.
9. rd edn. Baltimore, Wiliams and Wilkins. 1998; 139-56.
10. Bornschlegel K, Thomas P, Channing K, Saletan S, Kaye K. Tuberculosis in children born to HIV-infected women in New York City (Abstract). XI International Conference on AIDS, Vancouver, Canada. 1996.
11. Whalen C. Copathogenicity of tuberculosis and human immunodeficiency virus disease. Clin Infect Dis (In Press).
12. Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987; 238: 800-2.
13. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Natl Acad Sci USA 1989; 86: 2336-40.
14. Lederman MM, Georges DL, Kusner DJ, Mudido P, Giam CZ, Toossi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of human immunodeficiency virus. J Acquir Immune Defic Syndr 1994; 7: 727-33.
15. Zhang Y, Nakata K, Weiden M, Rom WN. Mycobacterium tuberculosis enhances human immunodeficiency virus -1 replication by transcriptional activation at the long terminal repeat. J Clin Invest 1995; 95: 2324-31.
16. Harries AD. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 1990; 335: 387-90.
17. Harries AD, Nyangulu DS, Kangombe C et al. The scourge of HIV-related tuberculosis : a cohort study in a district general hospital in Malawi. Ann Trop Med Parasitol 1997; 91: 771-6.
18. Perlman DC, El-Sadr,WM, Nelson ET et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. Clin Infect Dis 1997; 25: 242-6.
19. Mukadi YD, Witkor SZ, Coulibaly IM et al. Impact of HIV infection on the development, clinical presentation and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. AIDS 1997; 11: 1151-8.
20. Garay JE. Clinical presentation of pulmonary tuberculosis in under 10s and differences in AIDS-related cases: a cohort study of 115 patients. Trop Doctor 1997; 27: 139-42.
21. Topley JM, Bamber S, Coovadia HM, Corr PD. Tuberculous meningitis and co-infection with HIV. Ann Trop Paediatr 1998; 18: 261-6.
22. Jeena PM, Mitha T, Bamber S, Wesley A, Coutsoudis A, Coovadia HM. Effects of the human immunodeficiency virus on tuberculosis in children. Tuberc Lung Dis 1996; 77: 437-43.
23. American Academy of Pediatrics, Committee on Pediatric AIDS. Evaluation and medical treatment of the HIV-exposed infant. Pediatrics 1997; 99: 909-17.
24. Johnson JL, Vjecha MJ, Okwera A et al. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration, Int J Tuberc Lung Dis 1998; 2: 397-404.
25. Bekedam HJ, Boeree M, Kamenya A et al. Tuberculous lymphadenitis, a diagnostic problem in areas of high prevalence of HIV and tuberculosis. Trans Roy Soc Trop Med Hyg 1997; 91: 294-7.
26. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations. MMWR 1998; 47 (RR-20): 1-58.
27. Moore M, Onorato IM, McCray E, Castro KG. Trends in drug-resistant tuberculosis in United States, 1993-1996. JAMA 1997; 278: 833-7.
28. Narita M, Ashkin D, Hollender ES, Pitchenick AE. Paradoxical worsening of tuberculosis following anti-retroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158: 157-61.
29. Perriens JH, Colebunders RL, Karahunga C et al. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis 1991; 144: 750-5.
30. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991; 324: 289-94.
31. Witkor SZ, Sassan-Moroko M, Grant AD et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1 infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomized controlled trial. Lancet 199; 353: 1469-75.
32. O'Brien KL, Ruff AJ, Lous MA et al. Bacillus Calmette-Guerin complications in childrenborn to HIV 1-infected women with a review of the literature. Pediatrics 1995; 95: 414-8.
33. Bhat G, Diwan V, Chintu C, Kabika M, Masona J. HIV, BCG and tuberculosis in children. J Trop Paediatr 1993; 39: 219-23.